EUVIMEDEUVIMED entdecken
Crossref

Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology

Ramesh Nadarajah iD, Peter Ludman iD, Cécile Laroche, Yolande Appelman iD, Salvatore Brugaletta iD, Andrzej Budaj, Hector Bueno, Kurt Huber iD, Vijay Kunadian iD, Sergio Leonardi iD, Maddalena Lettino iD, Dejan Milasinovic iD und 1 weitere

European Heart Journal: Acute Cardiovascular Care · 2024

DOI: 10.1093/ehjacc/zuad134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2024. Verfasst von Ramesh Nadarajah und 12 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, 6 Clarendon Way, Leeds LS2 9DA, UK. Hauptthemen laut MEDLINE: Non-ST Elevated Myocardial Infarction, Myocardial Infarction, ST Elevation Myocardial Infarction, Cardiology. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Abbott Vascular Int, Amgen Cardiovascular, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Women have historically been disadvantaged in terms of care and outcomes for non-ST-segment elevation myocardial infarction (NSTEMI). We describe patterns of presentation, care, and outcomes for NSTEMI by sex in a contemporary and geographically diverse cohort. Methods and results Prospective cohort study including 2947 patients (907 women, 2040 men) with Type I NSTEMI from 287 centres in 59 countries, stratified by sex. Quality of care was evaluated based on 12 guideline-recommended care interventions. The all-or-none scoring composite performance measure was used to define receipt of optimal care. Outcomes included acute heart failure, cardiogenic shock, repeat myocardial infarction, stroke/transient ischaemic attack, BARC Type ≥3 bleeding, or death in-hospital, as well as 30-day mortality. Women admitted with NSTEMI were older, more comorbid, and more frequently categorized as at higher ischaemic (GRACE >140, 54.0% vs. 41.7%, P < 0.001) and bleeding (CRUSADE >40, 51.7% vs. 17.6%, P < 0.001) risk than men. Women less frequently received invasive coronary angiography (ICA; 83.0% vs. 89.5%, P < 0.001), smoking cessation advice (46.4% vs. 69.5%, P < 0.001), and P2Y12 inhibitor prescription at discharge (81.9% vs. 90.0%, P < 0.001). Non-receipt of ICA was more often due to frailty for women than men (16.7% vs. 7.8%, P = 0.010). At ICA, more women than men had non-obstructive coronary artery disease or angiographically normal arteries (15.8% vs. 6.3%, P < 0.001). Rates of in-hospital adverse outcomes and 30-day mortality were low and did not differ by sex.

Conclusion

In contemporary practice, women presenting with NSTEMI, compared with men, less frequently receive antiplatelet prescription, smoking cessation advice, or are considered eligible for ICA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-ST Elevated Myocardial InfarctionMyocardial InfarctionST Elevation Myocardial InfarctionCardiologyMaleHumansFemaleProspective StudiesRisk FactorsRegistries

Stichwörter der Autor:innen

MortalityNSTEMIQuality indicatorsRegistrySex

Autor:innen und Institutionen

  • Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, 6 Clarendon Way, Leeds LS2 9DA, UK.
  • Leeds Institute of Data Analytics, University of Leeds, UK.
  • Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
  • EURObservational Research Programme, European Society of Cardiology, European Heart House, 2035 Route des Colles, Sophia Antipolis, France.
  • Department of Cardiology, Amsterdam UMC-Vrije Universiteit, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.

ORCID-Profile: Ramesh Nadarajah, Peter Ludman, Yolande Appelman, Salvatore Brugaletta, Kurt Huber, Vijay Kunadian, Sergio Leonardi, Maddalena Lettino, Dejan Milasinovic

Förderung

  • Abbott Vascular Int
  • Amgen Cardiovascular
  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim
  • Boston Scientific
  • Bristol Myers Squibb and Pfizer Alliance
  • Daiichi Sankyo Europe GmbH

Zitieren

APA

Nadarajah, R., Ludman, P., Laroche, C., Appelman, Y., Brugaletta, S., Budaj, A., Bueno, H., Huber, K., Kunadian, V., Leonardi, S., Lettino, M., Milasinovic, D., & Gale, C. P. (2024). Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuad134

Vancouver

Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, et al. Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology. European Heart Journal: Acute Cardiovascular Care. 2024. doi:10.1093/ehjacc/zuad134

BibTeX
@article{Nadarajah2024,
  author = {Nadarajah, Ramesh and Ludman, Peter and Laroche, Cécile and Appelman, Yolande and Brugaletta, Salvatore and Budaj, Andrzej and Bueno, Hector and Huber, Kurt and Kunadian, Vijay and Leonardi, Sergio and Lettino, Maddalena and Milasinovic, Dejan and Gale, Chris P},
  title = {Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2024},
  doi = {10.1093/ehjacc/zuad134}
}
Kostenlos starten →